发明名称 |
Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators |
摘要 |
<p>A method for predicting the likelihood a mammal will respond therapeutically to a method of treating cancer comprising administering a VEGFR-2 modulator or a dual VEGFR-2 / FGFR-1 modulator wherein the method comprises: (a) measuring in the mammal the level of a biomarker; (b) either comparing the level of the biomarker in the sample relative to a standard to permit assignment of the sample to either being a member of a biomarker positive class or a biomarker negative class, or comparing the level of the biomarker in the sample relative to a standard, wherein assignment of the mammal to the biomarker positive sample class or a determination that the mammal has an elevated level of the biomarker, indicates an increased or decreased likelihood the patient will respond therapeutically to the cancer treatment. Methods of predicting whether a mammal has received an efficacious dose of a VEGFR-2 modulator or a dual VEGFR-2 / FGFR-1 modulator is also disclosed, in addition to kits comprising these methods.</p> |
申请公布号 |
EP2527467(A3) |
申请公布日期 |
2013.03.20 |
申请号 |
EP20120154822 |
申请日期 |
2008.04.11 |
申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
PARADA, JESUS PLATERO;GALBRAITH, SUSAN MARY |
分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|